P38/MAPK inhibitor modulates the expression of dorsal horn GABA(B) receptors in the spinal nerve ligation model of neuropathic pain

NeuroImmunoModulation

Volumn 18, Issue 3, 2011, Pages 150-155

  Wu, Junzhen ^a   Xu, Yongming ^a   Pu, Shaofeng ^a   Jiang, Wei ^a   Du, Dongping ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

GABA(B) receptor; Microglia; Neuropathic pain; p38 MAPK; Spinal nerve ligation

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; MALE; MICROGLIA; NERVE LIGATION; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD DORSAL HORN; SPINAL NERVE;

ANIMALS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GLIOSIS; LIGATION; MALE; MICROGLIA; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PERIPHERAL NERVOUS SYSTEM DISEASES; POSTERIOR HORN CELLS; PROTEIN KINASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-B;

EID: 78651411460     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000323141     Document Type: Article

References (31)

1. Woolf C, Mannion R: Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999; 353: 1959-1964.
2. Ji R, Wen Y: Neural-glial interaction in the spinal cord for the development and maintenance of nerve injury-induced neuropathic pain. Drug Dev Res 2006; 67:331-338. (Pubitemid 44277290)
3. Zhuang Z, Kawasaki Y, Tan P, Wen Y, Huang J, Ji R: Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injuryinduced cleavage of fractalkine. Brain Behav Immun 2007; 21: 642-651. (Pubitemid 46830963)
4. Watkins L, Hutchinson M, Milligan E, Maier S: 'Listening' and 'talking' to neurons: implications of immune activation for pain control and increasing the efficacy of opioids. Brain Res Brain Res Rev 2007; 56: 148-169. (Pubitemid 350100866)
5. Ji RR, Suter MR: p38 MAPK, microglial signaling, and neuropathic pain. Mol Pain 2007; 3: 33.
6. Milligan E, Sloane E, Watkins L: Glia in pathological pain: a role for fractalkine. J Neuroimmunol 2008; 198: 113-120.
7. Cámara-Lemarroy C, Guzmán-de la Garza F, Fernández-Garza N: Molecular inflammatory mediators in peripheral nerve degeneration and regeneration. Neuroimmunomodulation 2010; 17: 314-324.
8. Tsuda M, Inoue K, Salter M: Neuropathic pain and spinal microglia: a big problem from molecules in 'small' glia. Trends Neurosci 2005; 28: 101-107. (Pubitemid 40178927)
9. Inoue K: The function of microglia through purinergic receptors: neuropathic pain and cytokine release. Pharmacol Ther 2006; 109: 210-226. (Pubitemid 41740822)
10. Jin SX, Zhuang ZY, Woolf CJ, Ji RR: p38 mitogen- activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J Neurosci 2003; 23: 4017-4022. (Pubitemid 36958419)
11. Tsuda M, Mizokoshi A, Shigemoto-Mogami Y, Koizumi S, Inoue K: Activation of p38 mitogen- activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury. Glia 2004; 45:89-95. (Pubitemid 38076231)
12. Raghavendra V, Tanga F, DeLeo J: Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J Pharmacol Exp Ther 2003; 306: 624-630. (Pubitemid 36886161)
13. Milligan ED, Watkins LR: Pathological and protective roles of glia in chronic pain. Nat Rev Neurosci 2009; 10: 23-36.
14. Goudet C, Magnaghi V, Landry M, Nagy F, Gereau R, Pin J: Metabotropic receptors for glutamate and GABA in pain. Brain Research Reviews 2009; 60: 43-56.
15. Castro-Lopes J, Malcangio M, Pan B, Bowery N: Complex changes of GABAA and GABAB receptor binding in the spinal cord dorsal horn following peripheral inflammation or neurectomy. Brain Res 1995; 679: 289-297.
16. Yang L, Zhang F, Huang F, Lu Y, Li G, Bao L, Xiao H, Zhang X: Peripheral nerve injury induces trans-synaptic modification of channels, receptors and signal pathways in rat dorsal spinal cord. Eur J Neurosci 2004; 19: 871-883. (Pubitemid 38297024)
17. Engle M, Gassman M, Sykes K, Bettler B, Hammond D: Spinal nerve ligation does not alter the expression or function of GABAB receptors in spinal cord and dorsal root ganglia of the rat. Neuroscience 2006; 138: 1277-1287. (Pubitemid 43363544)
18. Chaplan S, Bach F, Pogrel J, Chung J, Yaksh T: Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994; 53: 55-63. (Pubitemid 24238751)
19. Kim S, Chung J: An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992; 50: 355-363.
20. Yaksh T, Rudy T: Chronic catheterization of the spinal subarachnoid space. Physiol Behav 1976; 17: 1031-1036. (Pubitemid 8063691)
21. Dobos I, Toth K, Kekesi G, Joo G, Csullog E, Klimscha W, Benedek G, Horvath G: The significance of intrathecal catheter location in rats. Anesth Analg 2003; 96: 487-492. (Pubitemid 36125770)
22. Ji R, Samad T, Jin S, Schmoll R, Woolf C: p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron 2002; 36: 57-68.
23. Wang XL, Zhang HM, Chen SR, Pan HL: Altered synaptic input and GABAB receptor function in spinal superficial dorsal horn neurons in rats with diabetic neuropathy. J Physiol 2007; 579: 849-861.
24. Davis-Taber R, Scott V: Transcriptional profiling of dorsal root ganglia in a neuropathic pain model using microarray and laser capture microdissection. Drug Dev Res 2006; 67:308-330. (Pubitemid 44277289)
25. Terayama R, Omura S, Fujisawa N, Yamaai T, Ichikawa H, Sugimoto T: Activation of microglia and p38 mitogen-activated protein kinase in the dorsal column nucleus contributes to tactile allodynia following peripheral nerve injury. Neuroscience 2008; 153: 1245-1255.
26. Inoue A, Ikoma K, Morioka N, Kumagai K, Hashimoto T, Hide I, Nakata Y: Interleukin- 1β induces substance p release from primary afferent neurons through the cyclooxygenase- 2 system. J Neurochem 1999; 73: 2206-2213. (Pubitemid 29491836)
27. Southall MD, Michael RL, Vasko MR: Intrathecal nsaids attenuate inflammation-induced neuropeptide release from rat spinal cord slices. Pain 1998; 78: 39-48. (Pubitemid 28451527)
28. McCarson K, Enna S: Nociceptive regulation of GABAB receptor gene expression in rat spinal cord. Neuropharmacology 1999; 38: 1767-1773. (Pubitemid 29430251)
29. Campbell J, Meyer R: Mechanisms of neuropathic pain. Neuron 2006; 52: 77-92. (Pubitemid 44466361)
30. Pocock J, Kettenmann H: Neurotransmitter receptors on microglia. Trends Neurosci 2007; 30: 527-535. (Pubitemid 47513237)
31. Margeta-Mitrovic M, Mitrovic I, Riley R, Jan L, Basbaum A: Immunohistochemical localization of GABAB receptors in the rat central nervous system. J Comp Neurol 1999; 405: 299-321. (Pubitemid 29104304)